Filing Details
- Accession Number:
- 0001225208-25-002186
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-21 21:35:20
- Reporting Period:
- 2025-02-19
- Filing Date:
- 2025-02-21
- Accepted Time:
- 2025-02-21 21:35:20
- SEC Url:
- Form 4 Filing
Issuer
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2016263 | M Uma Amuluru | 929 Long Bridge Drive Arlington VA 22202 | Evp And Chief Hr Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-02-19 | 8,291 | $0.00 | 22,371 | No | 4 | A | Direct | |
Common Stock | Disposition | 2025-02-20 | 3,159 | $180.69 | 19,213 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2025-02-19 | 23,513 | $0.00 | 23,513 | $221.44 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
23,513 | 2028-02-19 | 2035-02-19 | No | 4 | A | Direct |
Footnotes
- Represents restricted stock units of which 2,736 units will vest on February 19, 2026, 2,736 units will vest on February 19, 2027 and 2,819 units will vest on February 22, 2028; units settle in shares of the Company's common stock on a one-for-one basis.
- The price shown is a weighted average sale price for shares sold in multiple transactions; the sale prices ranged from $180.690 to $180.705 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- The exercise price is equal to 120% of the average of the high and low trading prices on the date of grant.
- The option becomes vested and exercisable in full on February 19, 2028, which is the third anniversary of the date of grant.